High-grade glioma expert group
Date:
03/12/2010
Location:
London, UK
The European Medicines Agency is holding this expert meeting to understand and discuss how anti-cancer medicines should be developed to treat children with high-grade glioma, a disease with a dismal prognosis and high unmet needs. Recent biological and clinical data, as well as experience from paediatric trials, is being discussed. Preliminary consequences for paediatric trials and further questions are being identified.
-
List item
Meeting report on the paediatric high-grade glioma medicines expert workshop (PDF/183.16 KB)
First published: 06/07/2011
Last updated: 06/07/2011
EMA/289125/2011 -
List item
List of questions: High-grade glioma expert meeting (PDF/142.98 KB)
First published: 06/07/2011
Last updated: 06/07/2011
EMA/608847/2010 -
List item
Presentation - Paediatric investigation plans for medicines to treat high-grade glioma (PDF/288.21 KB)
First published: 06/07/2011
Last updated: 06/07/2011 -
List item
Presentation - Paediatric high-grade glioma: Clinical background (PDF/873.26 KB)
First published: 06/07/2011
Last updated: 06/07/2011